MedPath

Nantes University Hospital

Nantes University Hospital logo
πŸ‡«πŸ‡·France
Ownership
Private
Established
1503-01-01
Employees
10K
Market Cap
-
Website
https://www.chu-nantes.fr

Clinical Trials

775

Active:23
Completed:409

Trial Phases

5 Phases

Phase 1:33
Phase 2:57
Phase 3:52
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (441 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
272 (61.7%)
Phase 2
57 (12.9%)
Phase 3
52 (11.8%)
Phase 1
33 (7.5%)
Phase 4
27 (6.1%)

Long-term Evaluation of Percutaneous Endoscopic Caecostomy in Refractory Constipation

Not yet recruiting
Conditions
Constipation
Refractory
First Posted Date
2025-09-08
Last Posted Date
2025-09-08
Lead Sponsor
Nantes University Hospital
Target Recruit Count
80
Registration Number
NCT07160192
Locations
πŸ‡«πŸ‡·

Nantes University Hospital, Nantes, Loire-Atlantique, France

Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator.

Not yet recruiting
Conditions
Subcutaneous Implantable Cardioverter
First Posted Date
2025-09-05
Last Posted Date
2025-09-05
Lead Sponsor
Nantes University Hospital
Target Recruit Count
1000
Registration Number
NCT07157449
Locations
πŸ‡«πŸ‡·

CHU de Nantes, Nantes, France

Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics

Not yet recruiting
Conditions
Severe Bacterial Infections
First Posted Date
2025-08-08
Last Posted Date
2025-08-08
Lead Sponsor
Nantes University Hospital
Target Recruit Count
1401
Registration Number
NCT07111793
Locations
πŸ‡«πŸ‡·

Nantes University Hospital, Nantes, Loire Atlantique, France

Pressure-Volume Loop Assessment in Valvular Heart Disease

Not yet recruiting
Conditions
Heart Failure
Structural Heart Disease
Interventional Cardiology
First Posted Date
2025-08-08
Last Posted Date
2025-09-08
Lead Sponsor
Nantes University Hospital
Target Recruit Count
70
Registration Number
NCT07112391

Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL

Not yet recruiting
Conditions
Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
First Posted Date
2025-08-01
Last Posted Date
2025-08-26
Lead Sponsor
Nantes University Hospital
Target Recruit Count
60
Registration Number
NCT07099443
Locations
πŸ‡«πŸ‡·

University Hospital, Nantes, France

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 155
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.